The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has authorised GSK’s Blenrep for treating multiple ...

GSK has secured the first regulatory approval for Blenrep since the antibody-drug conjugate’s global market withdrawal in 2022. | GSK has secured the first regulatory approval for Blenrep since the ...

GSK said on Thursday two combination therapies with its cancer drug, Blenrep, have received approval from British authorities ...

The annual per capita pharmaceutical sales are less than US$32. Most of this spent is out of the pocket. By providing a big portfolio of 140 products with a relative low price, GSK is winning the ...

GlaxoSmithKline Pharmaceuticals Limited is a subsidiary ... Also, they introduced the Animal health products. In the year 1971, the company built the Research & development laboratory at Thane.

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

The company recently secured approval for olezarsen in FCS, and looks odds on for a follow-up approval in SHTG. Click here to ...

For FTSE 100 businesses navigating the shifting sands of Trump’s trade war, the uncertainty surrounding the tariffs has been ...

Shares in GSK fell around 9% this morning ... The company and other pharma groups that have sold ranitidine products over the years have so far been fairly successful in fending off the litigation ...

This FTSE 100 firm's smaller than rivals but could benefit from its big US manufacturing footprint and competitive market ...